Latest Cytori Therapeutics Inc. Stories
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation NEW YORK and SAN DIEGO, Dec.
The first patient has been treated as part of The ATHENA Trial, which derives stem cells from the patient’s own adipose (fat) tissue and injects extracted cells into damaged parts of the heart.
Cytori Therapeutics, Inc., (NASDAQ:CYTX) will present and provide an audio webcast of its corporate presentation at the 2008 BIOCOM Investor Conference at 1:00 p.m. (Eastern Daylight Time) on Monday, October 27, 2008 at the Hyatt Regency La Jolla in California.
Cytori Therapeutics, Inc., (NASDAQ: CYTX) will present and provide an audio webcast of its corporate presentation at the Fourth Annual Noble Financial Equity Conference at 12:00 p.m. (Eastern Daylight Time) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada.
Cytori Therapeutics, Inc. (NASDAQ: CYTX) will release financial results for the quarter ended June 30, 2008 on Friday, Aug 8th at approximately 7:00 a.m. Eastern Daylight Time (EDT). The company will host a conference call with management at 10:30 a.m.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) reported positive preclinical results demonstrating adipose-derived stem and regenerative cells improved the quality and long-term retention of a fat graft, representing a potential new approach in reconstructive surgery.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.